A Study of Novel Study Interventions and Combinations in Participants With Colorectal Cancer

Recruiting now · Phase 2

Conditions studied: Metastatic Colorectal Cancer

In brief

The main purpose of this study is to evaluate the safety and efficacy of novel study interventions and combinations in participants with Colorectal Cancer (CRC).

Key facts

Study ID
NCT06792695
Run by
AstraZeneca
People needed
80
Starts
2025-03-12
Expected to finish
2028-09-29
Last updated by the study team
2026-07-13

Who can join

Age: 18 and older, up to 130. Sex: any. Healthy volunteers: not accepted.

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.